Aandelen in “Medische Specialiteiten”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Medische Specialiteiten”

07:00 · First quarter 2026 update: starting the year on track, with product innovation progress · Persbericht

07:00 · First quarter 2026 update: starting the year on track, with product innovation progress · Persbericht

20/05 · Nanalysis Announces First Quarter 2026 Results · Persbericht

20/05 · Atossa Therapeutics Announces Acceptance of Manuscript Highlighting Utrophin-Modulation Potential of (Z)-Endoxifen in Duchenne Muscular Dystrophy · Persbericht

20/05 · Information on the total number of voting rights and shares · Persbericht

20/05 · Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum · Persbericht

20/05 · Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain · Persbericht

20/05 · Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky · Persbericht

20/05 · QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences · Persbericht

20/05 · InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer · Persbericht

20/05 · IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions · Persbericht

19/05 · TransMedics to Present at the William Blair 46th Annual Growth Stock Conference · Persbericht

19/05 · IBA – ACQUISITION OF OWN SHARES · Persbericht

19/05 · FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints · Persbericht

18/05 · Waters Corporation to Present at the Jefferies Global Healthcare Conference · Persbericht

18/05 · Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 · Persbericht

18/05 · Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures · Persbericht

18/05 · Boston Scientific enters into $2 billion accelerated share repurchase agreement · Persbericht

18/05 · Artivion Completes Acquisition of Endospan Ltd. · Persbericht

18/05 · Peter Menziuso Named EVP and President, BD Interventional · Persbericht

18/05 · Boston Scientific announces strategic investment in MiRus LLC · Persbericht

Mijn selecties